False about familial polyposis colon cancer syndrome:
**Question:** False about familial polyposis colon cancer syndrome:
A. Polyps are benign in nature
B. The risk of developing colon cancer is significantly reduced after turning 50 years old
C. The condition is caused by mutations in the adenomatous polyposis coli (APC) gene
D. The symptoms are present at birth
**Correct Answer:** .
**Core Concept:** Familial Polyposis Colon Cancer Syndrome (FPCCS) is a hereditary disorder characterized by the development of multiple polyps in the colon, increasing the risk of colon cancer. FPCCS is caused by mutations in the adenomatous polyposis coli (APC) gene, which leads to the development of adenomatous polyps and subsequent colon cancer.
**Why the Correct Answer is Right:** Familial Polyposis Colon Cancer Syndrome is indeed caused by mutations in the APC gene. The APC gene is responsible for regulating cell growth and differentiation in the colon. When mutated, it promotes the uncontrolled growth of colon cells, leading to the development of polyps (adenomatous polyps in particular) and an increased risk of colon cancer.
**Why Each Wrong Option is Incorrect:**
A. Polyps are not always benign in nature. In fact, some polyps, particularly those from the adenomatous polyposis coli (APC) gene mutations, can be malignant and lead to colon cancer.
B. The risk of developing colon cancer is not significantly reduced after turning 50 years old in individuals with FPCCS. In fact, the risk remains high throughout life due to the genetic predisposition.
C. The incorrect statement in option C is that the symptoms are present at birth. The FPCCS typically presents with symptoms later in life, often in the third or fourth decade.
**Clinical Pearl:** The understanding of the genetic basis of FPCCS (APC gene mutations) and the knowledge of the malignant potential of polyps (adenomatous polyps) is essential in clinical practice. It allows healthcare professionals to monitor individuals with FPCCS more closely, perform regular colonoscopies, and detect colon cancer at an early stage, improving patient outcomes.